- Best Biomarker Testing Companies in 2025
- Medtronic initiates global pivotal study of cardiac pacing in a new patient population
- FUJIFILM Biosciences Introduces BalanCD HEK293 Perfusion A Medium to Enable Gene Therapy Production
- The Medical Device Industry | Innovations Drive Growth
- IVOS Medical Joins NIH’s C3i Program to Accelerate Commercialization of BOSS G4™ Airway Management Technology
- Nexus Spine Reports: Patented Tranquil® Interbody Implants Achieve Exceptional Outcomes
- Philips and Masimo announce innovation partnership to advance access to patient monitoring measurement technologies
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States
Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. We take pride in offering high-quality, in-depth content, crafted by a team of experienced professionals. Our goal is to provide a unique perspective on the trends and innovations driving the future of medical technology. By reading our articles, you’re not only gaining exclusive industry insights but also becoming part of a community committed to advancing healthcare through groundbreaking technologies. Explore our content and consider partnering with us for advertising opportunities!
“Medical Device News: Essential Key Insights and Noteworthy Developments Shaping the Future”
Sleep Apnea Threatens Women’s Cognitive Health | Ignored and Undiagnosed
Alzheimer’s disease affects more than 6 million Americans, and emerging research identifies Obstructive Sleep Apnea (OSA) as a significant, modifiable risk factor. Interrupted breathing during sleep can impair memory and accelerate cognitive decline, with growing evidence linking poor sleep to an increased risk of dementia. In response, Vivos Therapeutics is offering innovative, airway-centered treatments aimed at improving sleep quality and supporting long-term brain health.
Movora Becomes Exclusive Distributor of Aesculap Surgical Power Systems in North America
Guy Spörri, CEO of Movora said, “This agreement represents a significant step forward in our mission to support veterinary professionals with world-class surgical technologies.”
HNL Lab Medicine Opens New Location at Tower Place in Bethlehem
Leanne Anderson, Marketing Director at HNL Lab Medicine: “It’s important to us that children feel safe and parents feel supported. This new location is one more way we’re helping families get the care they need, close to home.”
Medtronic 1st in the U.S. to Offer 400 cm 0.018” Peripheral Guidewire for Transradial Access
This agreement includes the first 400 cm, 0.018″ peripheral guidewire available in the U.S, expanding the Medtronic portfolio for transradial access for the treatment of peripheral arterial disease (PAD).
Clinical Trials
Precision Study Underway – 100 Prostate Cancer Patients Treated in Just 3 Radiation Sessions
“The goal of the Precision Study is to ensure that treatment with three radiation doses does not lead to greater side effects than those observed in the Pace-B study. I am confident that we can demonstrate effective cancer treatment with less side effects,” says Professor McLaren.
City of Hope Opens Trial to Test Bone Medication for Early Type 1 Diabetes Treatment
“This is an exciting new application of a known medication that, in addition to potentially protecting and/or expanding the beta cells that remain in early type 1 diabetes patients, might also be able to help other patients with diabetes to increase beta cell number and/or function,” said Fouad R. Kandeel, M.D., Ph.D., the Arthur D. Riggs Distinguished Chair in Diabetes & Metabolism Research at City of Hope and the trial’s co-principal investigator. “We are actively working to enroll qualified patients and look forward to seeing where this trial leads us.”
REGENXBIO Reports Positive Biomarker Data from the AFFINITY DUCHENNE ®Trial of RGX-202 Gene Therapy
“RGX-202 is the only next generation gene therapy for Duchenne in a pivotal phase trial. The new data from the age 1-3 cohort builds on the favorable safety and efficacy profile seen in ages 4 and older and reinforces the potential of RGX-202 to serve a wide age range of patients,” said Steve Pakola, M.D., Chief Medical Officer of REGENXBIO.
Biotechnology News
Precision for Medicine and PathAI Announce Strategic Collaboration to Advance AI-Powered Clinical Trial Services and Biospecimen Products
Collaboration will deliver innovative AI-powered pathology tools and quality control enhancements to accelerate clinical trials and biomarker discovery.
VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies
VERAXA Biotech’s majority shareholders are Xlife Sciences AG (SIX: XLS), a Swiss-based publicly listed life science incubator fund, the European Molecular Biology Laboratory (“EMBL”), and its technology transfer arm EMBLEM.
Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma
The Institutional Review Board Has Approved the Increase in Number of Patients from Sixty (60) to Ninety (90). The Company to Expand the Study into Additional Trial Sites in Europe.
Our Experts – Byline Articles
Read Their Views & Share With a Colleague or Two!
5 Trends Shaping the IPO Market: Health to Fintech in 2025 | By Jack Horton
Jack Horton is a market analyst and tech industry researcher specializing in global IPO trends, emerging fintech ecosystems, and digital health innovation
Skin May Become the First Organ to Fulfill the Promise of Regenerative Medicine | By Dr. Ned Swanson – President & Chief Medical Officer of PolarityBio
The field of regenerative medicine may be on the cusp of an evolution, and due to the unique attributes of skin and wounds, the largest organ in the body may be emerging as a leader
Pinpointing the Invisible Source of Chronic Low Back Pain | By Brent Ness, CEO of Aclarion
Intense chronic low back pain (CLBP) is a global epidemic that plagues over 266 million people worldwide – we are not referring to the kind of sore back that you have after a long flight or weekend sleeping on your friend’s sofa, but rather the grinding, “drops you to your knees” pain that prevents you from going to work or school
FDA Medical Device Updates
Caranx Medical Announces FDA Submission of TAVIPILOT Soft: the World’s first AI Software for Real-time Intra-operative Guidance of Transcatheter Heart Valve Implantation
“This first release of our TAVIPILOT software marks an important step toward AI-augmented procedures. Our software is designed to be user-friendly, ensuring that cardiologists and surgeons can integrate it seamlessly into their usual practice. TAVIPILOT Soft allows clinicians to position a prosthetic valve easily and with high precision, ensuring that more patients could benefit from a high quality of care.” says Caranx Medical co-founder and CTO Pierre Berthet-Rayne.
Vergent Bioscience Receives FDA Fast Track Designation for Abenacianine for Injection (VGT-309) to Help Surgeons Visualize Tumors in the Lung During Surgery
“Receiving Fast Track designation from the FDA reinforces the potential of abenacianine to address existing deficits in lung cancer surgery by helping surgeons better visualize tumors in the lung during minimally invasive surgical procedures,” said John Santini, Ph.D., president and chief executive officer at Vergent Bioscience. “We look forward to collaborating with the FDA to make abenacianine available to surgeons and their patients as quickly as possible.”
Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding
Bright Uro Announces Oversubscribed $32M Series A Funding Round
Derek Herrera, founder and CEO of Bright Uro. “With this funding, we are well resourced for the launch of Glean in 2025, while also continuing to resource our pipeline of innovation. We have never been more confident in the expected impact Glean will have for clinicians and millions of patients suffering from urinary issues.”
Nuclera Closes $75 Million USD Financing
The funding will accelerate the commercialization of the Nuclera eProtein Discovery platform, to optimize protein expression and purification workflows within research labs globally
Biocomposites Invests in InfectoTest GmbH | Developers of a Bacterial-specific Point-of-care Test for Periprosthetic Joint infection
Michael Harris, Chief Executive Officer of Biocomposites, said: “Periprosthetic joint infection is a large and growing problem worldwide. Quickly and accurately pinpointing the bacteria that cause each infection is essential if patients are to receive the best care and maximise their chances of full recovery.
Syncona: Resolution Therapeutics Raises £63.5 Million in Series B Financing | Appoints New Chair
Use of proceeds from the Series B financing will support the clinical entry and development of RTX001, with a Phase I/II trial expected to start in Q4 CY2024. Following this financing, Resolution Therapeutics is funded to deliver data from this trial, anticipated in CY2026, a key value inflection point with the potential to drive significant NAV growth for Syncona. Proceeds will also be used to develop the company’s manufacturing platform, expand the pre-clinical pipeline, and further strengthen the management team, following several key recent appointments, including Dr Amir Hefni as CEO, Simon Ramsden as CFO and Dr Clifford A. Brass as CMO.
Market Reports
Advancements in Imaging
Philips Zenition 90 Motorized receives FDA 510(k) Clearance
“During complex procedures, it’s vital to be able to rely on surgical imaging systems. As clinicians navigate their way through challenging anatomy, the priority is to quickly visualize small anatomical details while limiting X-ray dose,” said Mark Stoffels, Business Leader Philips Image Guided Therapy Systems. “The new Zenition 90 Motorized empowers medical teams to confidently perform a wide range of interventions while achieving the best possible outcome for their patients.”
VUZE Medical Announces U.S. FDA 510(K) Clearance for Second-Generation Software-Based 3D Guidance System for Spine Surgery
VUZE 2.0 provides much-extended interoperability and functionality; like VUZE 1.0, requires only a 2D C-arm and PC in the OR — no cameras, markers, references or tool add-ons.
Nicklaus Children’s Health System, Philips Will Provide Innovative Patient & Staff Experience, Helping to Enhance Outcomes for the Smallest of Patients
Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic confidence.
Hospitals In the News
Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry
Non-Profit News
Healthcare - Understanding the Business Side of the Industry and Its Implications
Top 5 Patient Engagement Platforms Revolutionizing Healthcare
Patient engagement platforms are changing how healthcare is delivered by improving communication and handling administrative tasks. Read on.
Unveiling the Hidden Artistry: How Data Annotation Transforms Medical Imaging into AI Masterpieces
In the grand tapestry of modern medicine, artificial intelligence is weaving threads that are redefining diagnostics and patient care. But behind the scenes of every groundbreaking AI model lies a silent artist: the meticulous craft of data annotation. This unsung hero transforms ordinary medical images and videos into rich, informative datasets that teach AI how to “see” like a seasoned physician.
AI Detection of STEMI Equivalents: A Breakthrough in Emergency Cardiac Care
While ST-segment elevation myocardial infarction (STEMI) has traditionally been the cornerstone of heart attack diagnosis, a growing body of evidence highlights the importance of STEMI equivalents – ECG patterns indicating cardiac events that do not show classic ST-segment elevation but are just as dangerous.
Optimizing Emergency Medical Services With Advanced Patient Data Management
How Better Data Management Improves Emergency Medical Services In emergency medical services (EMS), each minute is valuable, and service response must occur fast enough to
Healthcare Careers
Nurses Corner
Collette Health Appoints Christine Gall as Chief Nursing Officer
Christine Gall will oversee all clinical operations and innovation initiatives to further enhance Collette Health’s commitment to helping hospitals integrate virtual patient safety solutions to prevent falls and adverse events and improve patient outcomes.
Symtech Systems Announces Nurse Call Systems Expected to Surge in Market Growth in 2024
By partnering with Symtech Solutions, healthcare facilities can benefit from cutting-edge nurse call systems that enhance patient care and increase staff productivity. The company’s commitment to delivering the best solutions combined with its industry expertise positions them as a trusted and reliable provider in the market
How Postgraduate Nursing Education Improves Patient Outcomes
In this article, we’ll examine the advantages of postgraduate education for nurses so that you can decide whether it’s the right path to take for your career.
